203 related articles for article (PubMed ID: 25711751)
1. Adverse drug reactions associated with the use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Machado-Alba JE; Ruiz AF; Machado-Duque ME
Rev Panam Salud Publica; 2014 Dec; 36(6):396-401. PubMed ID: 25711751
[TBL] [Abstract][Full Text] [Related]
2. Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions.
Abasolo L; Leon L; Rodriguez-Rodriguez L; Tobias A; Rosales Z; Maria Leal J; Castaño V; Vadillo C; Macarron P; Fontsere O; Jover JA
Semin Arthritis Rheum; 2015 Apr; 44(5):506-513. PubMed ID: 25532946
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab.
Sung YK; Cho SK; Kim D; Won S; Choi CB; Bang SY; Hong SJ; Kim HA; Koh EM; Lee HS; Suh CH; Yoo DH; Bae SC
Rheumatol Int; 2017 Jun; 37(6):1007-1014. PubMed ID: 28214924
[TBL] [Abstract][Full Text] [Related]
4. Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients.
Giraud EL; Jessurun NT; van Hunsel FPAM; van Puijenbroek EP; van Tubergen A; Ten Klooster PM; Vonkeman HE
Expert Opin Drug Saf; 2020 Dec; 19(12):1617-1624. PubMed ID: 32990050
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of gastrointestinal and hepatic adverse drug reactions in the treatment of rheumatoid arthritis with biomedical combination therapy and Chinese medicine.
Jiang M; Zha Q; He Y; Lu A
J Ethnopharmacol; 2012 Jun; 141(2):615-21. PubMed ID: 21782923
[TBL] [Abstract][Full Text] [Related]
6. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of treatment with biologic- and disease-modifying antirheumatic drugs in rheumatoid arthritis patients in Colombia.
Machado-Alba JE; Ruiz AF; Machado-Duque ME
Int J Clin Pract; 2016 Jun; 70(6):506-11. PubMed ID: 27238964
[TBL] [Abstract][Full Text] [Related]
8. Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
Leon L; Gomez A; Vadillo C; Pato E; Rodriguez-Rodriguez L; Jover JA; Abasolo L
Clin Exp Rheumatol; 2018; 36(1):29-35. PubMed ID: 28598787
[TBL] [Abstract][Full Text] [Related]
9. The temporal association between adverse drug reactions and antirheumatic drugs utilisation in Western Australia: a retrospective study from real-world data (1995-2015).
Almutairi KB; Inderjeeth CA; Preen DB; Keen HI; Nossent JC
Rheumatol Int; 2024 Jun; 44(6):1089-1099. PubMed ID: 38615313
[TBL] [Abstract][Full Text] [Related]
10. Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients.
Tan BE; Lim AL; Kan SL; Lim CH; Tsang EEL; Ch'ng SS; Mohd Noor N; Mohd Jamid N; Teh CL; Joshua Thundyil R; Loh YL; Chong HC; Ong SG; Mohamed Ismail A; Lee YYL; Gun SC
Rheumatol Int; 2017 Oct; 37(10):1719-1725. PubMed ID: 28695274
[TBL] [Abstract][Full Text] [Related]
11. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice.
Grove ML; Hassell AB; Hay EM; Shadforth MF
QJM; 2001 Jun; 94(6):309-19. PubMed ID: 11391029
[TBL] [Abstract][Full Text] [Related]
12. The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
Braun J; Kay J
Expert Opin Drug Saf; 2017 Mar; 16(3):289-302. PubMed ID: 28068848
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
[TBL] [Abstract][Full Text] [Related]
14. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases.
Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA
Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
Said MA; Silva LSTE; de Oliveira Rocha AM; Alves GGB; Piotto DGP; Len CA; Terreri MT
Adv Rheumatol; 2020 Nov; 60(1):53. PubMed ID: 33153496
[TBL] [Abstract][Full Text] [Related]
17. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database.
Petronijevic M; Ilic K; Suzuki A
Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):416-23. PubMed ID: 21370308
[TBL] [Abstract][Full Text] [Related]
18. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry.
Narongroeknawin P; Chevaisrakul P; Kasitanon N; Kitumnuaypong T; Mahakkanukrauh A; Siripaitoon B; Katchamart W;
Int J Rheum Dis; 2018 Jan; 21(1):170-178. PubMed ID: 28737837
[TBL] [Abstract][Full Text] [Related]
19. [The importance of patient perspective in drug surveillance systems].
Gäwert L; Hierse F; Zink A; Strangfeld A
Z Rheumatol; 2010 Nov; 69(9):795-802. PubMed ID: 21063828
[TBL] [Abstract][Full Text] [Related]
20. Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
Harigai M; Nanki T; Koike R; Tanaka M; Watanabe-Imai K; Komano Y; Sakai R; Yamazaki H; Koike T; Miyasaka N
Mod Rheumatol; 2016 Sep; 26(5):642-50. PubMed ID: 26873430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
